In Depth 29 May 2018
Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?
…by targeting epigenetics — the mechanisms by which gene expression is regulated. A Spanish biotech, Oryzon Genomics, has just started clinical trials with a drug that targets at once two…